[Biochemical substantiation of the use of inhibitors of the kinin system in complex treatment of allergic rhinosinusopathies].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D062365:Aminobenzoates / Q000627:therapeutic use*; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006967:Hypersensitivity / Q000201:enzymology; D007610:Kallikreins / Q000378:metabolism; D009297:Nasal Mucosa / Q000201:enzymology / Q000378:metabolism; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy* / Q000201:enzymology; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D000614:Aminocaproates; D062366:para-Aminobenzoates; D007611:Aprotinin; D007610:Kallikreins; D010129:4-Aminobenzoic Acid; D015119:Aminocaproic Acid
Razrabotka biokhimicheskikh obosnovaniĭ primeneniĭa ingibitorov kininovoĭ sistemy v kompleksnoĭ terapii allergicheskikh rinosinusopatiĭ.